B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $6.5

Benzinga Newsdesk www.benzinga.com Negative 96.6%

Neg 96.6% Neu 0% Pos 0%

B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $8 to $6.5.